Related Experiment Video
Updated: Oct 8, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Study of biallelic variants in CYP2R1 causing vitamin D hydroxylation deficiency rickets type 1B
Jiasheng Zhang1, Yuhui Huang2, Juan Li3
1Department of Laboratory Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China; Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Abstract:
Vitamin D hydroxylase deficiency rickets type 1B (VDDR1B) is a rare hereditary bone disease, due to a defect in vitamin D-25-hydroxylation. It is caused by mutations in CYP2R1, consistent with an autosomal recessive pattern. We aim to access the phenotype and investigate the genetic etiology of a pedigree with suspected rickets. The probands were a pair of identical twin girls, who had leg curvature and delayed independent ambulation with abnormal gait. X-rays showed valgus ribs and genu varum. The probands had taken vitamin D and calcium supplements since the age of 6 months. Their serum 25(OH)D levels were low but in a state of sufficiency, and decreased to mild deficiency one week after drug withdrawal. Whole genome sequencing revealed compound heterozygous variants of CYP2R1 (NM_024514.5), c.75_76insA (p.G26Rfs*68) and c.1115G > C (p.C372S), which were inherited from their parents, respectively. In vitro studies showed that CYP2R1 p.G26Rfs*68, the novel frameshift variant, was not expressed and completely lost its catalytic function, while CYP2R1 p.C372S showed decreased expression due to the activation of unfolded protein response signaling and partial loss of catalytic function. In conclusion, the biallelic variants of CYP2R1 were the genetic cause of rickets in this pedigree, expanding the mutation spectrum of CYP2R1, and facilitating the diagnosis of VDDR1B as well as subsequent treatment and efficacy surveillance of the probands.
Related Concept Videos
Pedigree Analysis
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
